Description
T3 Liothyronine Sodium + SR-9011 + Yohimbine research stack
T3 Liothyronine Sodium + SR-9011 + Yohimbine combines a thyroid hormone, a Rev-Erb agonist and an α2-adrenergic antagonist, as a transdermal or solution.
Product details
| Compound | Liothyronine (T3), SR-9011 and yohimbine |
|---|---|
| Class | Three-compound research formula |
| Form | Transdermal; Injectables |
| Strength | 60ml/17.6mg per ml/1g; 10ml/100mg per ml/1g |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What T3 Liothyronine Sodium + SR-9011 + Yohimbine research has examined
- T3: thyroid hormone signalling.
- SR-9011: circadian research.
- Yohimbine: adrenergic research.
Research interest does not establish a proven effect in humans.
Regulatory status
Licensed medicines containing this active ingredient are prescription-only products made by authorised manufacturers. The material sold here is a research chemical, not a licensed medicine, and is not approved for any use in humans.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from heat and light.
Related research products
T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal · S-23 + YK-11 + LGD-4033 + 5a Hydroxy Laxogenin Transdermal · Stenabolic (SR-9009) + Cardarine (GW-501516) · All transdermals
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.